by John Conrad | Jun 6, 2024 | NewsBrief
The biopharma sector has undergone significant changes in venture funding and investment trends during the first quarter of 2024, according to a recent PitchBook report. Despite a decrease in deal count, the sector saw an increase in venture funding, with $7.4 billion...
by John Conrad | Jun 4, 2024 | iBIO News
The biotech industry is facing a stark contrast between the robust state of scientific innovation and the challenging financial and economic environment, according to the latest EY Beyond Borders reportEY Beyond Borders report. While exciting advancements continue in...
